accounton... Speaking at the Reuters Health Summit on Tuesday, Chief Executive George Scangos said Biogen, which makes the multiple sclerosis drugs Avonex and Tysabri, is seeking to benefit from the potential of biosimilars without diluting the company's focus...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Biogen in talks with generic biotech partners
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account